Roy E. Ritts

2.8k total citations
65 papers, 2.1k citations indexed

About

Roy E. Ritts is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Roy E. Ritts has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 17 papers in Oncology and 16 papers in Surgery. Recurrent topics in Roy E. Ritts's work include Immunotherapy and Immune Responses (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Roy E. Ritts is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Roy E. Ritts collaborates with scholars based in United States, United Kingdom and Serbia. Roy E. Ritts's co-authors include Vincent R. Zurawski, George D. Malkasian, Henry A. Pitt, V. L. W. Go, Thomas L. Klug, Ronald B. Herberman, Bert C. Del Villano, Robert C. Bast, Gregory J. Gores and Nicholas F. LaRusso and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Roy E. Ritts

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roy E. Ritts United States	25	598	568	540	335	335	65	2.1k
C. H. Buckley United Kingdom	34	588 1.0×	541 1.0×	526 1.0×	474 1.4×	1.1k 3.2×	106	3.1k
Robert L. Young United States	20	283 0.5×	329 0.6×	563 1.0×	377 1.1×	131 0.4×	34	2.2k
Suresh H. Advani India	25	415 0.7×	1.1k 1.9×	309 0.6×	578 1.7×	159 0.5×	250	3.0k
Shuen‐Kuei Liao Taiwan	28	752 1.3×	408 0.7×	260 0.5×	788 2.4×	107 0.3×	117	2.3k
A Cattan France	23	554 0.9×	766 1.3×	228 0.4×	545 1.6×	43 0.1×	101	2.1k
Peyton T. Taylor United States	29	298 0.5×	597 1.1×	673 1.2×	262 0.8×	545 1.6×	72	2.2k
Rodrigue Mortel United States	38	587 1.0×	1.1k 2.0×	939 1.7×	526 1.6×	1.4k 4.1×	122	4.6k
Arzu Ensarı Türkiye	27	467 0.8×	585 1.0×	979 1.8×	431 1.3×	141 0.4×	142	3.0k
Bernardo Ruiz United States	25	508 0.8×	491 0.9×	1.7k 3.2×	527 1.6×	280 0.8×	51	3.0k
Fiona Graeme‐Cook United States	31	157 0.3×	708 1.2×	1.1k 2.0×	488 1.5×	302 0.9×	85	2.9k

Countries citing papers authored by Roy E. Ritts

Since Specialization

Citations

This map shows the geographic impact of Roy E. Ritts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy E. Ritts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy E. Ritts more than expected).

Fields of papers citing papers by Roy E. Ritts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy E. Ritts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy E. Ritts. The network helps show where Roy E. Ritts may publish in the future.

Co-authorship network of co-authors of Roy E. Ritts

This figure shows the co-authorship network connecting the top 25 collaborators of Roy E. Ritts. A scholar is included among the top collaborators of Roy E. Ritts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy E. Ritts. Roy E. Ritts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ritts, Roy E., et al.. (1994). Comparison of Preoperative Serum CA19-9 Levels with Results of Diagnostic Imaging Modalities in Patients Undergoing Laparotomy for Suspected Pancreatic or Gallbladder Disease. Pancreas. 9(6). 707–716. 60 indexed citations

Gores, Gregory J., et al.. (1993). Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis. Mayo Clinic Proceedings. 68(9). 874–879. 159 indexed citations

Bast, Robert C., A A Epenetos, B Dhokia, et al.. (1991). Coordinate elevation of serum markers in ovarian cancer but not in benign disease. Cancer. 68(8). 1758–1763. 45 indexed citations

Ritts, Roy E.. (1990). Antibiotics as biological response modifiers. Journal of Antimicrobial Chemotherapy. 26(suppl C). 31–36. 40 indexed citations

Malkasian, George D., Robert C. Knapp, Philip T. Lavin, et al.. (1988). Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease. American Journal of Obstetrics and Gynecology. 159(2). 341–346. 171 indexed citations

Zurawski, Vincent R., Nina Einhorn, Peter Kenemans, et al.. (1988). An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecologic Oncology. 30(1). 7–14. 87 indexed citations

O'Connell, M J, Joseph P. Colgan, Martin M. Oken, et al.. (1986). Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.. Journal of Clinical Oncology. 4(2). 128–136. 95 indexed citations

Smithson, William A., R. A. Siem, Roy E. Ritts, et al.. (1978). Response to influenza virus vaccine in children receivingchemotherapy for malignancy. The Journal of Pediatrics. 93(4). 632–634. 34 indexed citations

Woods, John E. & Roy E. Ritts. (1977). The influence of nonspecific immunotherapy on the course of Murine Melanoma. Journal of Surgical Oncology. 9(1). 15–20. 1 indexed citations

10.

Mueller‐Eckhardt, C. & Roy E. Ritts. (1976). Inhibitory activity of medium-dialyzed transfer factor on lymphocyte blastogenesis. Annals of Hematology. 32(5). 353–360. 4 indexed citations

11.

Ritts, Roy E., et al.. (1976). Phagocytosis and Cutaneous Delayed Hypersensitivity in Patients with Chronic Obstructive Pulmonary Disease. CHEST Journal. 69(4). 474–478. 2 indexed citations

12.

Moertel, Charles G., Roy E. Ritts, Allan J. Schutt, & Richard G. Hahn. (1975). Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.. PubMed. 35(11 Pt 1). 3075–83. 48 indexed citations

13.

Briggs, William A., et al.. (1975). Studies of Mitogen-induced Lymphocyte Transformation by a Semi-microtechnic. American Journal of Clinical Pathology. 64(1). 41–47. 16 indexed citations

14.

Hepburn, Bonnie, et al.. (1975). Suppression of Lymphocyte Transformation after Aspirin Ingestion. New England Journal of Medicine. 292(5). 221–223. 68 indexed citations

15.

Ritts, Roy E., et al.. (1974). An Overview of Cancer Immunology. Mayo Clinic Proceedings. 49(2). 118–131.

16.

Aiuti, F, J C Cerottini, R.R.A. Coombs, et al.. (1974). Identification, Enumeration, and Isolation of B and T Lymphocytes from Human Peripheral Blood. Scandinavian Journal of Immunology. 3(5). 521–532. 287 indexed citations

17.

Neel, H. Bryan & Roy E. Ritts. (1973). Tumor-Specific Immunity and the Otolaryngologist. Annals of Otology Rhinology & Laryngology. 82(3). 323–329. 3 indexed citations

18.

Ritts, Roy E.. (1971). The Immunology of Malignant Disease.. Archives of Internal Medicine. 128(5). 838–838. 20 indexed citations

19.

Markowitz, Harold, Donald A. Person, Gary Gitnick, & Roy E. Ritts. (1969). Immunosuppressive Activity of Concanavalin A. Science. 163(3866). 476–476. 38 indexed citations

20.

Ritts, Roy E., et al.. (1964). Electrophoresis of Serum Proteins on Cellulose-Acetate. American Journal of Clinical Pathology. 41(3_ts). 321–331. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact